Wouter J. Kikkert

Hilversum, NH, Netherlands

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 62 publications

Correction to: Combined strategy of upfront CTCA and optimal treatment for stable chest pain: rationale and design of the CLEAR-CAD trial.

Correction to: Combined strategy of upfront CTCA and optimal treatment for stable chest pain: rationale and design of the CLEAR-CAD trial.

Journal: Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation

Published: August 12, 2026

Genotype-Guided P2Y12-Inhibitor De-Escalation Strategy in Acute Coronary Syndrome: Observational Evidence From the POPular-GUIDE PCI.

Genotype-Guided P2Y12-Inhibitor De-Escalation Strategy in Acute Coronary Syndrome: Observational Evidence From the POPular-GUIDE PCI.

Journal: Circulation. Cardiovascular interventions

Published: February 26, 2026

Genotype-Guided P2Y12-Inhibitor De-Escalation Strategy in Acute Coronary Syndrome: Observational Evidence From the POPular-GUIDE PCI.

Genotype-Guided P2Y12-Inhibitor De-Escalation Strategy in Acute Coronary Syndrome: Observational Evidence From the POPular-GUIDE PCI.

Journal: Circulation. Cardiovascular interventions

Published: February 26, 2026

Sex differences in the presentation and management of acute coronary syndrome patients: Insights from the FORCE-ACS registry.

Sex differences in the presentation and management of acute coronary syndrome patients: Insights from the FORCE-ACS registry.

Journal: International journal of cardiology. Heart & vasculature

Published: October 09, 2025

Extension of the GRACE score for non-ST-elevation acute coronary syndrome: a development and validation study in ten countries.

Extension of the GRACE score for non-ST-elevation acute coronary syndrome: a development and validation study in ten countries.

Journal: The Lancet. Digital health

Published: January 06, 2025

Treatment Modifications in Acute Coronary Syndrome Patients Treated with Ticagrelor: Insights from the FORCE-ACS Registry.

Treatment Modifications in Acute Coronary Syndrome Patients Treated with Ticagrelor: Insights from the FORCE-ACS Registry.

Journal: Thrombosis and haemostasis

Published: October 29, 2024

Cost-effectiveness of implementing a genotype-guided de-escalation strategy in patients with acute coronary syndrome.

Cost-effectiveness of implementing a genotype-guided de-escalation strategy in patients with acute coronary syndrome.

Journal: European heart journal. Cardiovascular pharmacotherapy

Published: September 17, 2024

Combined strategy of upfront CTCA and optimal treatment for stable chest pain: rationale and design of the CLEAR-CAD trial.

Combined strategy of upfront CTCA and optimal treatment for stable chest pain: rationale and design of the CLEAR-CAD trial.

Journal: Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation

Published: September 10, 2024

Real-World Implementation of a Genotype-Guided P2Y12 Inhibitor De-Escalation Strategy in Acute Coronary Syndrome Patients.

Real-World Implementation of a Genotype-Guided P2Y12 Inhibitor De-Escalation Strategy in Acute Coronary Syndrome Patients.

Journal: JACC. Cardiovascular interventions

Published: January 28, 2024

Impact of recurrent ischaemic and bleeding events on quality of life in patients with acute coronary syndrome: Insights from the FORCE-ACS registry.

Impact of recurrent ischaemic and bleeding events on quality of life in patients with acute coronary syndrome: Insights from the FORCE-ACS registry.

Journal: Open heart

Published: June 30, 2023

One-year follow-up of patients treated with single antiplatelet therapy directly after percutaneous coronary intervention for non-ST-segment elevation acute coronary syndrome.

One-year follow-up of patients treated with single antiplatelet therapy directly after percutaneous coronary intervention for non-ST-segment elevation acute coronary syndrome.

Journal: European heart journal open

Published: June 05, 2023

Less bleeding by omitting aspirin in non-ST-segment elevation acute coronary syndrome patients: Rationale and design of the LEGACY study.

Less bleeding by omitting aspirin in non-ST-segment elevation acute coronary syndrome patients: Rationale and design of the LEGACY study.

Journal: American heart journal

Published: May 26, 2023

Showing 1-12 of 62

Last Updated: 09/26/2026